Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible...

Prof David Cairns - University of Leeds, Leeds, UK

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible patients with NDMM ( Prof David Cairns - University of Leeds, Leeds, UK )

Myeloma highlights from ASH 2019

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Myeloma highlights from ASH 2019 ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

FLT3-inhibition in infants with acute lymphoblastic leukaemia

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

FLT3-inhibition in infants with acute lymphoblastic leukaemia ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )

Chronic lymphocytic leukaemia highlights from ASH 2019

Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia

Chronic lymphocytic leukaemia highlights from ASH 2019 ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )

Benefits of apixaban among venous thromboembolism patients with active cancer

Dr Alexander Cohen - Guys and St Thomas, London, UK

Benefits of apixaban among venous thromboembolism patients with active cancer ( Dr Alexander Cohen - Guys and St Thomas, London, UK )

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in...

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )

Dasatinib vs imatinib for paediatric Ph ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA

Dasatinib vs imatinib for paediatric Ph ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )

Study of quadruple combination for induction resistant myeloma reveals novel...

Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints ( Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel )

KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM

Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria

KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM ( Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria )

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma

Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma ( Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )

Eligibility criteria in acute myeloid leukaemia clinical trials

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA

Eligibility criteria in acute myeloid leukaemia clinical trials ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )

More from ecancer